Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-16 Sale | 2024-08-20 4:45 pm | Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO | 67,015 | $0.072 | $4,825 | 265,029 (Direct) | View |
| 2014-04-17 Purchase(A) | 2024-05-01 5:02 pm | Galera Therapeutics Inc. | GRTX | Schneid Yair 10% Owner | 2,780,407 | $0.21235 | $590,424 | 10,823,610 (Direct) | View |
| 2024-01-11 Sale | 2024-04-01 9:36 pm | Galera Therapeutics Inc. | GRTX | Altamont Pharmaceutical Holdings LLC Pearson Mark E. 10% Owner | 4,200,000 | $0.1933 | $811,848 | 1,080,000 (Indirect) | View |
| 2024-01-29 Purchase | 2024-02-26 4:06 pm | Galera Therapeutics Inc. | GRTX | Schneid Yair 10% Owner | 932,402 | $0.17848 | $166,417 | 8,043,203 (Direct) | View |
| 2023-03-16 Purchase | 2023-03-20 4:05 pm | Galera Therapeutics Inc. | GRTX | Bachleda Mark Chief Commercial Officer | 11,000 | $2.247 | $24,717 | 11,000 (Direct) | View |
| 2023-03-10 Purchase | 2023-03-14 08:30 am | Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO | 100,000 | $1.6812 | $168,120 | 332,044 (Direct) | View |
| 2023-03-13 Purchase | 2023-03-14 08:30 am | Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer | 10,000 | $1.9593 | $19,593 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-05-16 10:26 am | N/A N/A | Galera Therapeutics Inc. | GRTX | Soffer Rochel ALPHA PHARMA Investments LLC 10% Owner | 0 | $0 | 5,928,137 (Direct) | View |
Ownership | 2024-01-16 6:11 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Schneid Yair 10% Owner | 0 | $0 | 7,110,801 (Direct) | View |
Ownership | 2023-11-13 2:22 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Altamont Pharmaceutical Holdings LLC Pearson Mark E. 10% Owner | 0 | $0 | 5,280,000 (Indirect) | View |
| 2023-07-01 Option Award | 2023-07-05 4:19 pm | N/A 2033-06-30 | Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director | 22,762 | $0 | 22,762 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-05 4:11 pm | N/A 2033-06-30 | Galera Therapeutics Inc. | GRTX | West Linda Director | 23,382 | $0 | 23,382 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:15 pm | N/A 2033-06-13 | Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:15 pm | N/A 2033-06-13 | Galera Therapeutics Inc. | GRTX | West Linda Director | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:15 pm | N/A 2033-06-13 | Galera Therapeutics Inc. | GRTX | LOKAY KEVIN G Director | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:15 pm | N/A 2033-06-13 | Galera Therapeutics Inc. | GRTX | Cunningham Emmett Director | 48,000 | $0 | 0 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:15 pm | N/A 2033-06-13 | Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-02-25 Option Award | 2023-02-28 7:06 pm | N/A 2033-02-24 | Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-25 Option Award | 2023-02-28 7:03 pm | N/A 2033-02-24 | Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO | 440,000 | $0 | 440,000 (Direct) | View |
| 2023-02-25 Option Award | 2023-02-28 6:57 pm | N/A 2033-02-24 | Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer | 185,000 | $0 | 185,000 (Direct) | View |
| 2023-02-25 Option Award | 2023-02-28 6:57 pm | N/A 2033-02-24 | Galera Therapeutics Inc. | GRTX | Kennedy Eugene P. Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2023-02-25 Option Award | 2023-02-28 6:56 pm | N/A 2033-02-24 | Galera Therapeutics Inc. | GRTX | Bachleda Mark Chief Commercial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-25 Option Award | 2023-02-28 6:56 pm | N/A 2033-02-24 | Galera Therapeutics Inc. | GRTX | Stacey Jennifer Evans See Remarks | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-11-21 Exercise | 2022-11-22 4:05 pm | N/A 2022-11-25 | Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer | 10,000 | $0 | 183,842 (Direct) | View |
| 2022-11-21 Exercise | 2022-11-22 4:05 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer | 10,000 | $1.07 | 183,842 (Direct) | View |
| 2022-09-12 Exercise | 2022-09-13 4:10 pm | N/A 2022-11-25 | Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer | 10,000 | $0 | 183,842 (Direct) | View |
| 2022-09-12 Exercise | 2022-09-13 4:10 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer | 10,000 | $1.07 | 183,842 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 4:15 pm | N/A 2032-08-31 | Galera Therapeutics Inc. | GRTX | Kennedy Eugene P. Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-07-18 Gift | 2022-07-20 06:05 am | N/A N/A | Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director | 4,000 | $0 | 10,370 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-05 4:05 pm | N/A 2032-06-30 | Galera Therapeutics Inc. | GRTX | West Linda Director | 58,496 | $0 | 58,496 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:06 pm | N/A 2032-06-14 | Galera Therapeutics Inc. | GRTX | LOKAY KEVIN G Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:05 pm | N/A 2032-06-14 | Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:05 pm | N/A 2032-06-14 | Galera Therapeutics Inc. | GRTX | West Linda Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:05 pm | N/A 2032-06-14 | Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:05 pm | N/A 2032-06-14 | Galera Therapeutics Inc. | GRTX | Cunningham Emmett Director | 15,000 | $0 | 0 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 4:06 pm | N/A 2032-02-27 | Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 4:06 pm | N/A 2032-02-27 | Galera Therapeutics Inc. | GRTX | Stacey Jennifer Evans See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 4:05 pm | N/A 2032-02-27 | Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 4:05 pm | N/A 2032-02-27 | Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 4:05 pm | N/A 2032-02-27 | Galera Therapeutics Inc. | GRTX | Bachleda Mark Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 4:05 pm | N/A 2032-02-27 | Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO | 264,400 | $0 | 264,400 (Direct) | View |